The company's low ROE and stagnant net income growth are una...
The company's low ROE and stagnant net income growth are unappealing. Despite high profit retention, the low ROE indicates that investors may not be reaping the benefits. The recent decision to pay dividends may signal a change in management's approach to shareholder returns.
Does The Market Have A Low Tolerance For Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's (SZSE:301130) Mixed Fundamentals?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment